Coronary intervention in patients with diabetes, chronic renal disease, and the elderly: therapeutic implications

Rev Cardiovasc Med. 2007:8 Suppl 3:S35-41.

Abstract

Patients with diabetes mellitus, chronic renal disease, or advanced age who are undergoing percutaneous coronary intervention are at an increased risk of bleeding and thrombosis. This article reviews the clinical implications of these conditions and discusses the therapeutic options currently available for these patient groups.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon, Coronary / adverse effects*
  • Anticoagulants / therapeutic use
  • Blood Coagulation
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / prevention & control
  • Diabetes Complications / blood
  • Diabetes Complications / etiology*
  • Diabetes Complications / prevention & control
  • Fibrinolytic Agents / therapeutic use
  • Hemorrhage / blood
  • Hemorrhage / etiology*
  • Hemorrhage / prevention & control
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use
  • Renal Insufficiency, Chronic / blood
  • Renal Insufficiency, Chronic / complications*
  • Risk Factors
  • Thrombosis / etiology
  • Treatment Outcome

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors